Kerala High Court Affirms Government Power to Address Exorbitant Patented Drug Prices
The Kerala High Court ruled that the Central government has the legal authority under Section 100 of the Patents Act, 1970, to manufacture or authorize production of patented life-saving medicines and supply them to needy patients on a non-commercial basis when prices are exorbitant. The case originated from a breast cancer patient’s plea for affordable access to the drug Ribociclib, who died before resolution. The court emphasized that the government must first collect data on affordability and patient need before deciding on intervention, leaving the final decision to the government’s discretion.
First-hand measurement across 7 sources
We measured how 7 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (59/100). Lens Score 62/100.
Outlets measured: news18, thefinancialexpress, moneycontrol, freepressjournal, indiatoday, ndtv, thehindu. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–62/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thehindu broke this story on 28 Sept, 06:53 am. Other outlets followed.